BEDFORD, Mass.--(BUSINESS WIRE)--Avila Therapeutics, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced today that Katrine Bosley, Avila’s CEO, is scheduled to present at the Stifel Nicolaus 2011 Healthcare Conference at 8:00 a.m. ET on Friday, September 9, 2011, at the Four Seasons Hotel, Boston.
